Immune dysfunction in patients with end stage kidney disease; Immunosenescence - Review
The body's defense against environmental factors is realized by physical barriers and cells of both the innate and adaptive immune systems. Patients with end stage kidney disease (ESKD), especially those treated by hemodialysis, have changes in both the function and the number or percent of dif...
Saved in:
Main Authors: | Bumbea Viorica Ileana (Author), Bumbea Horia (Author), Vladareanu Ana Maria (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease
by: Onisâi Minodora, et al.
Published: (2019) -
Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
by: Alessandra D'Abramo, et al.
Published: (2014) -
HIV as a Cause of Immune Activation and Immunosenescence
by: T. Sokoya, et al.
Published: (2017) -
The Role of Immunosenescence in Neurodegenerative Diseases
by: Erica Costantini, et al.
Published: (2018) -
The Impact of Immunosenescence on Pulmonary Disease
by: Michelle A. Murray, et al.
Published: (2015)